AI4CoV: Matching COVID-19 Patients to Treatment Options Using Artificial Intelligence
AI4CoV: Matching COVID-19 Patients to Treatment Options Using Artificial Intelligence
Abstract We developed AI4CoV, a novel AI system to match thousands of COVID-19 clinical trials to patients based on each patient’s eligibility to clinical trials in order to help physicians select treatment options for patients. AI4CoV leveraged Natural Language Processing (NLP) and Machine Learning to parse through eligibility criteria of trials and patients’ clinical manifestations in their clinical notes, both presented in English text, to accomplish 92.76% AUROC on a cross-validation test with 3,156 patient-trial pairs labeled with ground truth of suitability. Our retrospective multiple-site review shows that according to AI4CoV, severe patients of COVID-19 generally have less treatment options suitable for them than mild and moderate patients and that suitable and unsuitable treatment options are different for each patient. Our results show that the general approach of AI4CoV is useful during the early stage of a pandemic when the best treatments are still unknown.
Yeh Amber S.、Lv DongQing、Hsu Andrew I.、Chen Shao-Lang、Yeh Jerry J.、Hsu Jane Y.-J.、Huang Pai Jung
AI4WARD, Inc., 481 Gemma Drive MilpitasDepartment of Respiratory Medicine, Taizhou Hospital of Zhejiang Province, Wenzhou Medical UniversityAI4WARD, Inc., 481 Gemma Drive MilpitasAI4WARD, Inc., 481 Gemma Drive MilpitasAI4WARD, Inc., 481 Gemma Drive MilpitasDepartment of Computer Science & Information Engineering, National Taiwan UniversityClinical Trial Center at TaiZhou Medical Center, No 1, Tongyang East Road, Luqiao district||Breast Surgery Clinic, Surgery Department, En Chu Kong Hospital, No. 399, Fuxing Road, Sanxia District||Institute of Medical Science and Technology, Taipei Medical University
医学研究方法计算技术、计算机技术临床医学
Yeh Amber S.,Lv DongQing,Hsu Andrew I.,Chen Shao-Lang,Yeh Jerry J.,Hsu Jane Y.-J.,Huang Pai Jung.AI4CoV: Matching COVID-19 Patients to Treatment Options Using Artificial Intelligence[EB/OL].(2025-03-28)[2026-08-26].https://www.medrxiv.org/content/10.1101/2020.11.29.20240614.点此复制
评论